Toward a paradigm shift: Oral agents and injectable drugs in the future of obesity management

Abstract

The escalating global burden of obesity has emerged as a critical health crisis of the modern era, requiring efficient pharmaceutical interventions to stem the tide. Indeed, few topics have garnered as much attention and urgency as this mounting global pandemic. The prevalence of obesity has reached alarming proportions, making it one of the most pressing health crises of the 21st century. With its detrimental impact on individuals and society, there is an urgent need to find effective pharmacotherapies to combat this epidemic.